DD01

D&D Pharmatech

Drug Candidate

DD01

Summary

Potential Best-in-Class Long-acting GLP-1R/GCGR Dual Agonist

Mechanism of Action

Long-acting GLP-1R/GCGR Dual Agonist

Indication

Obesity/Diabetes/NASH

Development Stage

Phase I